Navigation Links
Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films
Date:9/16/2008

BETHLEHEM, Pa., Sept. 16 /PRNewswire/ -- Particle Sciences, Inc. announces the issuing of its patent (US7,419,527) on a unique system for increasing the density of sintered metal products. The technology allows for the processing of powdered metals in a way that decreases needed injection forces, decreases lubricant requirements and results in structurally superior end-products. It is based on a proprietary coating applied to the powders prior to sintering. "This could both increase the quality of the finished product and substantially decrease the environmental impact of the manufacturing process," says Garry Gwozdz, Director of Formulation and one of the inventors at Particle Sciences. Particle Sciences is a CRO primarily focused on pharmaceutical applications. This technology is an offshoot of some of their nano-particle work involving a unique drug delivery approach. "This is pretty far from our core business so we intend to out-license the technology. It could dovetail nicely with an earlier technology we developed and patented (US6,045,650) involving the coating of surfaces with metal oxides, titanium dioxide for instance. The '527 provides for sintered metal products with improved physical characteristics and lowered carbon footprint. The '650 technology allows for the application of low cost carefully controlled, even printable, metal oxide surface coatings. Both of these technologies came out of our efforts in the pharmaceutical arena but clearly have broader applicability so we intend to partner with companies that can better take advantage of the opportunities," says Dr. Mark Mitchnick, CEO of Particle Sciences. For more information, visit http://www.particlesciences.com.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.

Contact:

Maureen Cochran

mcochran@particlesciences.com


'/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Particle Sciences Develops Zero-Order-Release Combination Device Technology
2. New disease-fighting nanoparticles look like miniature pastries
3. Nanoparticles + light = dead tumor cells
4. Using magenetic nanoparticles to combat cancer
5. Nanoparticle Stops Cancer From Spreading
6. Waves, particles and medicine in Houston
7. Smart bomb nanoparticle strategy impacts metastasis
8. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
9. Nanoparticles aid bone growth
10. Magnetic nanoparticles: Suitable for cancer therapy?
11. Brown chemists create cancer-detecting nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... to the OSEHRA popHealth Community in 2014. It is the culmination ... the Developer Open Source Project Group. OSEHRA Organizational Member Zato Health co-funded the ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... announced it will co-exhibit with technology partners LG Business Solutions at ATARC ... Metro Center in Washington D.C., will provide education and examination into the mobility ...
(Date:3/27/2017)... ... March 27, 2017 , ... Adding to its ... Journal of Medicine and NEJM Journal Watch, announces the release of NEJM ... by a panel of pediatricians from leading medical centers. The content was then ...
(Date:3/27/2017)... Rock, AR (PRWEB) , ... March 27, 2017 , ... ... CMSA National Board of Directors on June 30, 2017. CMSA’s membership has elected ... In addition to our current Military Advisory position, a new VA Advisory position has ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may be ... groin injury, it occurs when the muscles around the pelvis become inflamed. Over ... the lower torso, as well as accompanying tenderness and weakness. Without proper intervention, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
(Date:3/27/2017)...  Twist Bioscience, a company accelerating science and innovation ... raised an additional $33 million. To date, Twist Bioscience ... "It is an exciting time to be leading ... to deliver industry-leading gene volume to our customers, enabling ... Leproust, Ph.D., CEO of Twist Bioscience. "We welcome the ...
(Date:3/27/2017)... , March 27, 2017   Genprex, Inc. , a ... Julien Pham , MD, the Company,s Chief Operating Officer, is ... conferences. Sachs 5th Annual Cancer BioPartnering & Investment ... New York, NY ... BioCentury 24th Annual Future Leaders in Biotech ...
Breaking Medicine Technology: